EW

Q: What is the price of Edwards Lifesciences (EW) today?

The current price of Edwards Lifesciences (EW) is $ 85.78, representing a 14.39% gain over the past year. The stock began the year trading around $ 85.25 and is currently priced at $ 85.78. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Edwards Lifesciences (EW) pay dividends?

Edwards Lifesciences (EW) did not pay dividends over the past year.

Edwards Lifesciences Corp.

Price

$ 85.78

return (12m)

14.39%

p/e

45.45

p/bv

4.81

DIVIDEND YIELD

0.00%

EW price

Edwards Lifesciences

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.94%

3 months

4.10%

1 year

14.39%

2 years

-1.45%

5 years

-9.08%

10 years

161.26%

Fundamentals EW

review the fundamentals of Edwards Lifesciences shares

P/E

45.45

Sector: -1.52 Industry: 0.92

P/S (PSR)

7.88

Sector: 1.96 Industry: 0.67

P/BV

4.81

Sector: 2.09 Industry: 2.29

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

8.20%

Sector: -27.99% Industry: -15.42%

ROE

10.58%

Sector: -33.59% Industry: -29.67%

ROIC

20.30%

Sector: -438.25% Industry: -111.96%

NET MARGIN

17.34%

Sector: -29.78% Industry: -16.97%

GROSS MARGIN

77.87%

Sector: 45.32% Industry: 31.10%

OPERATING MARGIN

27.62%

Sector: -24.45% Industry: -7.65%

EV/EBITDA

31.86

Sector: 0.02 Industry: 0.98

EV/EBIT

35.52

Sector: -1.32 Industry: 2.85

PRICE-TO-ASSETS

3.73

Sector: 1.14 Industry: 0.85

BVPS

17.84

Sector: 3.88 Industry: 5.17

EPS

1.89

Sector: -0.92 Industry: -0.57

EQUITY-TO-ASSETS RATIO

0.78

Sector: 0.43 Industry: 0.26

LIABILITIES / ASSETS

0.22

Sector: 0.46 Industry: 0.48

CAGR REVENUE 5 YEARS

3.79%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-6.18%

Sector: - Industry: -

FAIR VALUE OF Edwards Lifesciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 85.78

Fair Value

$ 0.00

Upside/Downside Return potential.

-67.89%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals EW

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	37.67	30.52	81.02%	0.59%	$ 952.11 B	34.99%
ISRG	52.21	8.84	16.93%	0.00%	$ 155.53 B	28.15%
SNY	7.24	1.29	17.79%	4.99%	$ 108.11 B	14.75%
TMO	24.35	3.20	13.15%	0.39%	$ 166.76 B	15.15%
NVS	21.44	7.45	34.77%	2.04%	$ 290.19 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.86	2.05	9.38%	3.61%	$ 100.84 B	13.00%
GSK	13.07	4.41	33.77%	3.44%	$ 102.50 B	17.79%
CVS	40.49	1.53	3.78%	2.85%	$ 118.72 B	0.72%
BSX	24.23	3.34	13.78%	0.00%	$ 86.38 B	17.29%
TMDX	13.63	4.74	34.80%	0.00%	$ 2.34 B	27.04%
HCA	12.99	-29.64	-228.14%	0.75%	$ 88.27 B	8.89%
IDXX	40.86	28.76	70.38%	0.00%	$ 44.75 B	24.63%
RMD	19.85	4.65	23.41%	1.12%	$ 30.17 B	27.44%
DHR	33.01	2.30	6.97%	0.79%	$ 121.78 B	14.89%
INMD	9.93	1.31	13.18%	0.00%	$ 865.62 M	23.27%
PHG	21.85	1.87	8.56%	3.42%	$ 24.68 B	5.50%
SYK	36.22	5.26	14.52%	1.09%	$ 120.87 B	13.21%
FMS	10.81	0.72	6.71%	3.64%	$ 11.90 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EW Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Edwards Lifesciences

Edwards Lifesciences Corp.

Average Investor10 user rating

4.0 (13 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

14.900

Employees

Edwards Lifesciences Corp. (United States) is listed on the NYSE and has a market capitalization of $49.67 Billions, with shareholders equity totaling $10.33 Billions.

The company employs approximately 14.900 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Edwards Lifesciences Corp. reported $6.30 Billions in revenue, generating net income of $1.09 Billion.

Key financial metrics include a P/E ratio of 45.45, a price-to-book (P/B) ratio of 4.81, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EW.

Market cap

$ 49.67 Billions

Net worth

$ 10.33 Billions

$ 10,327,500,000.00

Assets

$ 13.32 Billions

$ 13,321,200,000.00

Total Shares Outstanding

579.00 Millions

579,000,000

Average Daily Trading Volume

$ 4.92 Millions

$ 4,917,538.00

Sector

Health

Industry

Medical Supplies and Equipment

revenue by Business Segment Edwards Lifesciences

Revenue by Region Edwards Lifesciences

EW revenue and profits

Financial Results EW

DRAG THE FRAME TO SEE MORE DATA

EW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 93.26 58,90% (12M)

P/E

40.49

2.85%

ROE

3.78%

P/BV

1.53

CI - Cigna

$ 286.24 --7,00% (12M)

P/E

11.64

2.13%

ROE

15.39%

P/BV

1.79

CNC - Centene

$ 59.14 4,84% (12M)

P/E

-4.52

0.00%

ROE

-29.93%

P/BV

1.35

HUM - Humana

$ 307.95 39,47% (12M)

P/E

32.70

1.15%

ROE

6.06%

P/BV

1.98

SNY - Sanofi

$ 44.29 --7,52% (12M)

P/E

7.24

4.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,065.00 48,20% (12M)

P/E

37.67

0.59%

ROE

81.02%

P/BV

30.52

HCA - HCA Healthcare

$ 394.07 5,54% (12M)

P/E

12.99

0.75%

ROE

-228.14%

P/BV

-29.64

NVS - Novartis

$ 152.01 37,44% (12M)

P/E

21.44

2.04%

ROE

34.77%

P/BV

7.45